Acadia Healthcare (NASDAQ:ACHC) Rating Increased to Hold at StockNews.com

StockNews.com upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a sell rating to a hold rating in a research report released on Thursday.

Other equities research analysts have also issued research reports about the company. Barclays dropped their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Royal Bank of Canada cut their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Finally, KeyCorp initiated coverage on Acadia Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $75.44.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $38.59 on Thursday. The firm has a market cap of $3.58 billion, a P/E ratio of 12.65, a PEG ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm’s 50 day moving average price is $44.14 and its two-hundred day moving average price is $61.09.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same period in the prior year, the business earned $0.91 EPS. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts forecast that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of hedge funds have recently made changes to their positions in the business. Wellington Management Group LLP raised its stake in Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after acquiring an additional 1,266,384 shares during the period. William Blair Investment Management LLC increased its holdings in shares of Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after purchasing an additional 604,070 shares during the last quarter. State Street Corp raised its position in shares of Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after purchasing an additional 95,613 shares during the period. Point72 Asset Management L.P. lifted its stake in shares of Acadia Healthcare by 0.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after buying an additional 12,470 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in Acadia Healthcare by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after buying an additional 14,197 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.